Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Progressive Multiple Sclerosis
NCT01450488Phase 2Completed
- Sponsor
- AB Science
- Start
- Jun 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of masitinib in primary progressive multiple sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), sponsored by AB Science. Started Jun 2005; status: completed.
02
Drugs
masitinib
03
Conditions
primary progressive multiple sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01450488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450488.